Literature DB >> 15596845

Human cytomegalovirus tegument protein pp71 directs long-term gene expression from quiescent herpes simplex virus genomes.

Chris M Preston1, Mary Jane Nicholl.   

Abstract

The human cytomegalovirus tegument protein pp71 is important for transactivation of immediate-early (IE) gene expression and for the efficient initiation of virus replication. We have analyzed the properties of pp71 by assaying its effects on gene expression from the genome of in1312, a herpes simplex virus type 1 (HSV-1) mutant devoid of functional VP16, ICP0, and ICP4. Upon infection of human fibroblasts, in1312-derived viruses are repressed and retained in a quiescent state, but the presence of pp71 prevented the quiescent state from being attained. Reporter gene cassettes cloned into the in1312 genome, in addition to the endogenous IE promoters, remained active for at least 12 days postinfection, and infected cells were viable and morphologically normal. Cells expressing pp71 remained responsive to the HSV-1 transactivating factors VP16 and ICP4 and to trichostatin A. The C-terminal 61 amino acids, but not the LACSD motif, were required for pp71 activity. In addition to preventing attainment of quiescence, pp71 was able to disrupt the quiescent state of in1312 derivatives and promote the resumption of viral gene expression after a lag of approximately 3 days. The results extend the functional analysis of pp71 and suggest a degree of similarity with the HSV-1 IE protein ICP0. The ability to provoke slow reactivation of quiescent genomes, in conjunction with cell survival, represents a novel property for a viral structural protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596845      PMCID: PMC538741          DOI: 10.1128/JVI.79.1.525-535.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.

Authors:  W E Hobbs; D E Brough; I Kovesdi; N A DeLuca
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

3.  The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro.

Authors:  Chris Boutell; Seth Sadis; Roger D Everett
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx.

Authors:  Heike Hofmann; Hilde Sindre; Thomas Stamminger
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Association of herpes simplex virus type 1 ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzyme.

Authors:  Changhong Zhou; David M Knipe
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Complementation of a herpes simplex virus type 1 Vmw110 deletion mutant by human cytomegalovirus.

Authors:  E C Stow; N D Stow
Journal:  J Gen Virol       Date:  1989-03       Impact factor: 3.891

8.  Activity and intracellular localization of the human cytomegalovirus protein pp71.

Authors:  Ker R Marshall; Kate V Rowley; Angela Rinaldi; Iain P Nicholson; Alexander M Ishov; Gerd G Maul; Chris M Preston
Journal:  J Gen Virol       Date:  2002-07       Impact factor: 3.891

9.  Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains.

Authors:  Alexander M Ishov; Olga V Vladimirova; Gerd G Maul
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.

Authors:  A M Ishov; A G Sotnikov; D Negorev; O V Vladimirova; N Neff; T Kamitani; E T Yeh; J F Strauss; G G Maul
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

View more
  30 in total

Review 1.  Virion factors that target Daxx to overcome intrinsic immunity.

Authors:  Sabrina Schreiner; Harald Wodrich
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

2.  Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.

Authors:  Yoshitaka Miyagawa; Pietro Marino; Gianluca Verlengia; Hiroaki Uchida; William F Goins; Shinichiro Yokota; David A Geller; Osamu Yoshida; Joseph Mester; Justus B Cohen; Joseph C Glorioso
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

3.  Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression.

Authors:  Ryan T Saffert; Robert F Kalejta
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a).

Authors:  Emilia Vanni; Derek Gatherer; Lily Tong; Roger D Everett; Chris Boutell
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

5.  Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx.

Authors:  Vera Lukashchuk; Roger D Everett
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

6.  Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection.

Authors:  Mandy Glass; Roger D Everett
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

7.  Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both?

Authors:  Ryan T Saffert; Robert F Kalejta
Journal:  Future Virol       Date:  2008-05-01       Impact factor: 1.831

8.  Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  Future Virol       Date:  2012-09-01       Impact factor: 1.831

9.  STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts.

Authors:  Roger D Everett; Dan F Young; Rick E Randall; Anne Orr
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

10.  Properties of virion transactivator proteins encoded by primate cytomegaloviruses.

Authors:  Iain P Nicholson; Jane S Sutherland; Tanya N Chaudry; Earl L Blewett; Peter A Barry; Mary Jane Nicholl; Chris M Preston
Journal:  Virol J       Date:  2009-05-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.